Great Basin Scientific Inc. (fka GBSNQ)

[MWolverine]

Salt Lake City, January 24, 2017 - Great Basin Scientific, Inc. (OTCQB: GBSND), a molecular diagnostics company, today reported preliminary financial
results for the fourth quarter ended December 31, 2016.
Fourth Quarter 2016 Financial Results and Business Highlights:
· Revenue increased 39.2% to $851,930 compared with the same quarter in 2015;
· Revenue increased 15.8% over the third quarter 2016;
· 2016 revenue was $3,048,126 up 42.3% over fiscal year 2015;
· Group B. Strep test revenue increased 274% to $150,570 compared with a year ago, and 38.5% quarter over quarter;
· Newly launched Shiga Toxin Direct Test and Staph ID/R Blood Culture Panel revenues were $51,720 combined; and
· Submitted 510(k) application for Stool Pathogens Panel to the FDA.